We followed previous experimental protocols in which we found estrogen administration is robustly effective in protecting against endothelial dysfunction via abrogation of ACE2 upregulation, and ACE2-dependent activation of NOX2 and MCP-1 (23). Here, CCL2 is linked to endothelial dysfunction.